oa SA Pharmaceutical Journal - Jurnista® : hydromorphone extended-release tablets : new product focus : drug info
|Article Title||Jurnista® : hydromorphone extended-release tablets : new product focus : drug info|
|© Publisher:||Medpharm Publications|
|Journal||SA Pharmaceutical Journal|
|Publication Date||Apr 2012|
|Pages||28 - 30|
Osmotic controlled-release oral delivery system (OROS®) hydromorphone extended-release (Jurnista®) is a once-daily formulation of the opioid agonist hydromorphone that uses OROS® technology to deliver the analgesic at a near-constant rate over the 24-hour dosing interval. OROS® technology is used in a number of commercially available medicines, and OROS® hydromorphone was developed to provide 24-hour analgesia for severe pain, and as a result, lessen the need for breakthrough pain medication.
Article metrics loading...